IDEAS home Printed from https://ideas.repec.org/h/pal/gpochp/978-3-032-20355-7_5.html

ResponsibilityResponsibility

In: The Economics of Pain

Author

Listed:
  • John E. Schneider

    (Avalon Health Economics)

Abstract

Based on the causal factors identified in Chapter 4, a total of 15 groupings of potentially responsible parties (“PRPs”) can be identified. The number of PRPs could be somewhat higher or lower depending on how entities are identified within each contributing factor. This number is considerably larger than the tripartite identified in the 1970 CSA and the recent Ohio abatement order in the MDL, which consisted only of manufacturers, distributors, and pharmacies. There is substantial evidence supporting the identification of these groups of entities as having some role in the opioid crisis, with some of them having an arguably causative or enabling role. While it may be conceptually convenient to fall back on the three traditional members of the pharmaceutical supply chain in considering issues related to liability, the U.S. opioid crisis provides a useful example of why the three supply chain entities constitute a narrow portrayal of the modern-day pharmaceutical supply chain. As many experts have argued, it is difficult to conceive of the growth in prescription opioid supply beginning in the early 2000s as being possible without the “perfect storm” of actions and inactions on the part of several of the contributing factors and associated PRP groups. In product liability cases with multiple causal factors and multiple defendants, it is usually necessary to develop a fair and equitable allocation model to apportion responsibility for harms (e.g., attributable costs and abatement costs) among PRP groups. In cases where volumetric approaches are not practical, allocation approaches have been somewhat more arbitrary, based on fair and reasonable approximations. The latter approach was taken in the opioid MDL, where the presence of three defendant PRP groups encouraged an apportionment of one-third of abatement responsibility to one of the categories (retail pharmacies) and the remaining two thirds to be distributed among the other two PRP groups. The approach to allocation was somewhat arbitrary, which suggests that other allocation methods would also work, assuming reasonable arguments can be made to support such allocation approaches.

Suggested Citation

  • John E. Schneider, 2026. "ResponsibilityResponsibility," Global Perspectives on Wealth and Distribution, in: The Economics of Pain, chapter 5, pages 265-295, Palgrave Macmillan.
  • Handle: RePEc:pal:gpochp:978-3-032-20355-7_5
    DOI: 10.1007/978-3-032-20355-7_5
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:gpochp:978-3-032-20355-7_5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.palgrave.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.